Compliance professionals across the life sciences industry faced growing pressure from evolving enforcement priorities, geopolitical uncertainty, China-related risks, AI challenges, and increased scrutiny surrounding fraud, False Claims Act exposure, cartels, and transnational criminal organizations (TCOs). ACI’s FCPA and Anti-Corruption Conference for the Life Sciences Industry delivered practical guidance, enforcement updates, and actionable strategies to help organizations strengthen compliance programs and reduce risk in an increasingly complex global environment.

Attendees gained critical insights from regulators, industry leaders, and experienced counsel on how to navigate emerging risks, enhance third-party oversight, improve investigations and monitoring, and build more resilient compliance frameworks. The conference provided the tools and peer benchmarking needed to stay ahead of enforcement trends and prepare for the future of compliance in the life sciences sector.